| Today's Open | $1.25 |
|---|---|
| Previous Close | $1.25 |
| Daily Range | $1.23 - $1.33 |
| 52-Week Range | $1.02 - $3.94 |
| Market Cap | $149.8M |
| P/E Ratio | -0.72 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,950,987 |
| Average Daily Volume | 953,409 |
| Current FY EPS | -$0.61 |
Sector
Healthcare
Industry
Drugs
Cell Therapeutics, Inc. (CTIC) Description
The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer. Website: http://www.celltherapeutics.com/
News & Commentary
5 Companies That Haven't Earned Their Keep
Investors should understand that these five companies have only done one thing well lately: Lose money.
Chelsea's Northera might be approvable after all.
CTIC's Top Competitors
(6.40%)
(2.44%)
(1.78%)
(1.47%)